Welcome to LookChem.com Sign In|Join Free
  • or
1,4-bis(1'-bromoethyl)benzene is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

17194-87-5

Post Buying Request

17194-87-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

17194-87-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 17194-87-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,1,9 and 4 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 17194-87:
(7*1)+(6*7)+(5*1)+(4*9)+(3*4)+(2*8)+(1*7)=125
125 % 10 = 5
So 17194-87-5 is a valid CAS Registry Number.

17194-87-5Relevant academic research and scientific papers

Amphiphilic polymer conetworks prepared by controlled radical polymerization using a nitroxide cross-linker

Zhao, Weijie,Fang, Ming,He, Junpo,Chen, Junyu,Tang, Wei,Yang, Yuliang

scheme or table, p. 4141 - 4149 (2011/11/28)

Tandem atom transfer radical polymerization (ATRP) and nitroxide-mediated radical polymerization (NMRP) were used to synthesize a polystyrene-co- poly(acrylic acid) (poly(St-co-AA)) network, in which the two components were interconnected by covalent bond

New carbamoylpiperidines as human platelet aggregation inhibitors

Guo, Zhengming,Zheng, Xiaozhang,Thompson, Walter,Dugdale, Marion,Gollamudi, Ram

, p. 1041 - 1058 (2007/10/03)

A series of 3-carbamoylpiperidines (nipecotamides) are designed, synthesized and tested for their inhibitory action against adenosine diphosphate (ADP)-induced aggregation of human platelets. A structure- activity analysis of the bis(nipecotamido)aralkane type showed that a substituent on the piperidine ring should preferably be an amide and that the electronegativity of the carbonyl oxygen and the orientation of the amide group affected activities. Based on the knowledge of factors influencing platelet activation and aggregation, a nitric ester moiety which could release nitric oxide (NO) in situ, is incorporated into the nipecotamide structure. These compounds exhibit increased activity compared to those having no -ONO2 function. They also show stereoselectivity, with the meso isomer being approximately twice as potent as the synthetic diastereomeric mixture. Replacement of the -ONO2 function with hydroxyl, ester or alkyl groups considerably diminishes aggregation-inhibitory potential. Nipecotamides are shown here to inhibit the basal and collagen-induced rise in platelet inositol trisphosphate (IP3) levels, as well as phosphoinositide turnover. A comprehensive mechanism of action is proposed taking earlier results into consideration. (C) 2000 Elsevier Science Ltd.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 17194-87-5